Brief: Prostatype Study Results To Be Presented At World's Top Urology Meeting
Aug 24 (Reuters) - Prostatype Genomics AB PROGEN.ST :
* PROSTATYPE ® P-SCORE AND PROGNOSTIC EVALUATION IN PROSTATE
CANCER TO BE PRESENTED AT THE LARGEST UROLOGY MEETING IN THE
WORLD
* P-SCORE HAS SHOWN BETTER PREDICTION PERFORMANCE FOR
PROSTATE
CANCER-SPECIFIC DEATH AND METASTASIS THAN EAU RISK
CLASSIFICATION
Source text for Eikon: ID:nWkr1Gjmn7
Further company coverage: PROGEN.ST
(Gdansk Newsroom)
((Gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))
Recent news on Prostatype Genomics AB
See all newsBrief: Prostatype Genomics Cannot Specify Timing For Final Medicare Decision
Brief: Prostatype Genomics Enters SEK 6.0 Mln Agreement With Vator Securities For To6
Brief: Prostatype Genomics AB H1 2026 Net Sales SEK 457,000
Brief: Prostatype Genomics Resolves On Directed Issue
Brief: Prostatype Genomics To Receive About SEK 47.4 Mln From Rights Issue